See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $438B | 7.4x | 16.2x | |
| $397B | 4.7x | 16.9x | |
| $250B | 4.9x | 20.5x | |
| $180B | 2.6x | 12.3x | |
| $75.7B | 3.7x | 15.2x | |
| $70.9B | 9.6x | 42.0x | |
| $69.7B | 1.3x | 6.2x | |
| $61.3B | 3.2x | 11.5x | |
| $53.8B | 3.6x | 14.4x | |
| $47.6B | 3.1x | 13.7x | |
| $44.3B | 4.8x | 19.7x | |
| $42.2B | 8.5x | 37.2x | |
| $39.2B | 2.7x | 19.4x | |
| $33.9B | 1.4x | 7.7x | |
| $25.9B | 2.2x | 14.6x | |
| $24.0B | 3.9x | 17.1x | |
| $22.6B | 2.3x | 6.6x | |
| $22.4B | 1.9x | 11.2x | |
| $21.1B | 1.4x | 7.8x | |
| $20.7B | 1.8x | 12.4x | |
| $15.1B | 8.8x | 42.1x | |
| $12.9B | 2.2x | 15.9x | |
| $12.7B | 8.4x | 32.9x | |
| $11.2B | 2.0x | 9.7x | |
| $10.9B | 7.3x | 39.3x | |
| $10.8B | 8.1x | 42.4x | |
| $9.5B | 1.4x | 8.0x | |
| $8.0B | 1.2x | 11.8x | |
| $7.9B | 1.3x | 7.4x | |
| $7.5B | 10.7x | 32.9x | |
| $7.3B | 5.0x | 22.9x | |
| $6.4B | 1.5x | 8.6x | |
| $6.3B | 7.0x | 16.4x | |
| $6.2B | 2.2x | 9.7x | |
| $5.8B | 7.0x | 29.0x | |
| $5.1B | 11.4x | 36.0x | |
| $5.0B | 10.0x | 40.5x | |
| $4.8B | 1.6x | 11.2x | |
| $4.5B | 4.1x | 26.3x | |
| $4.2B | 3.7x | 11.3x | |
| $4.1B | 2.5x | 13.5x | |
| $4.0B | 1.8x | 11.5x | |
| $3.9B | 1.2x | 6.9x | |
| $3.7B | 11.5x | 43.8x | |
| $3.7B | 2.5x | 12.7x | |
| $3.7B | 1.7x | 10.3x | |
| $3.6B | 1.1x | 6.9x | |
| $3.3B | 4.4x | 21.0x | |
| $3.0B | 2.9x | 13.0x | |
| $2.9B | 6.5x | 24.0x | |
| $2.6B | 1.0x | 5.2x | |
| $2.6B | 0.6x | 6.0x | |
| $2.5B | 6.9x | 19.4x | |
| $2.5B | 0.9x | 7.2x | |
| $2.4B | 0.7x | 4.8x | |
| $2.4B | 1.2x | 9.1x | |
| $2.4B | 0.4x | 4.1x | |
| $2.3B | 2.9x | 19.1x | |
| $2.3B | 1.0x | 7.3x | |
| $2.2B | 1.3x | 10.4x | |
| $2.1B | 3.7x | 18.2x | |
| $2.0B | 1.8x | 13.9x | |
| $2.0B | 1.0x | 8.2x | |
| $1.9B | 1.7x | -57.4x | |
| $1.9B | 2.8x | 13.9x | |
| $1.7B | 5.8x | 14.6x | |
| $1.7B | 0.7x | 8.1x | |
| $1.5B | 1.2x | 8.6x | |
| $1.5B | 2.4x | 10.2x | |
| $1.5B | 0.8x | 5.8x | |
| $1.3B | 0.6x | 5.3x | |
| $1.2B | 1.7x | 7.0x | |
| $1.2B | 8.3x | 28.7x | |
| $1.1B | 1.6x | 11.7x | |
| $1.1B | 4.2x | 85.3x | |
| $1.0B | 2.4x | 9.7x | |
| $770M | 1.0x | 5.4x | |
| $748M | n/a | n/a | |
| $733M | 0.6x | 6.7x | |
| $688M | n/a | n/a | |
| $660M | 1.5x | 7.2x | |
| $645M | 0.4x | n/a | |
| $641M | n/a | n/a | |
| $613M | 0.2x | 1.5x | |
| $590M | 2.9x | -43.8x | |
| $578M | 2.0x | -40.1x | |
| $542M | 0.8x | 5.7x | |
| $518M | 1.3x | 8.5x | |
| $418M | 1.4x | 17.2x | |
| $416M | n/a | n/a | |
| $383M | n/a | n/a | |
| $375M | 1.5x | n/a | |
| $373M | 1.0x | 13.7x | |
| $354M | 1.2x | 8.8x | |
| $337M | 2.2x | 8.5x | |
| $326M | 0.8x | 9.4x | |
| $278M | 1.2x | 11.8x | |
| $278M | n/a | n/a | |
| $261M | n/a | n/a | |
| $228M | 0.4x | 11.4x | |
| $223M | 4.9x | 17.5x | |
| $204M | 1.0x | 6.8x | |
| $192M | 1.0x | 9.6x | |
| $191M | 1.0x | 4.7x | |
| $189M | n/a | n/a | |
| $179M | 2.3x | 12.5x | |
| $147M | n/a | n/a | |
| $138M | 0.5x | 6.3x | |
| $135M | 2.4x | 8.8x | |
| $97.9M | n/a | n/a | |
| $83.6M | 0.3x | 5.8x | |
| $61.0M | n/a | n/a | |
| $52.1M | 1.1x | 7.6x | |
| $50.1M | 2.1x | 8.1x | |
| $41.9M | n/a | n/a | |
| $37.8M | n/a | n/a | |
| $31.4M | n/a | n/a | |
| $24.8M | 1.9x | n/a | |
| $20.7M | 0.8x | -45.7x | |
| $19.2M | n/a | n/a | |
| $13.9M | n/a | n/a | |
| $13.6M | n/a | n/a | |
| $12.6M | n/a | n/a | |
| $5.9M | n/a | n/a | |
| $3.4M | 0.0x | 0.2x | |
| $1.1M | n/a | n/a | |
| $1.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty